Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
29.73
+5.45 (22.45%)
Oct 29, 2025, 11:00 AM EDT - Market open
Beta Bionics Stock Forecast
Stock Price Forecast
The 11 analysts that cover Beta Bionics stock have a consensus rating of "Strong Buy" and an average price target of $27, which forecasts a -9.18% decrease in the stock price over the next year. The lowest target is $17 and the highest is $32.
Price Target: $27 (-9.18%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beta Bionics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 5 | 5 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Reiterates $28 → $32 | Strong Buy | Reiterates | $28 → $32 | +7.64% | Oct 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $26 → $32 | Buy | Reiterates | $26 → $32 | +7.64% | Oct 29, 2025 |
| Stifel | Stifel | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | -12.55% | Oct 21, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $18 → $26 | Hold → Strong Buy | Upgrades | $18 → $26 | -12.55% | Oct 1, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $28 | Strong Buy | Maintains | $21 → $28 | -5.82% | Sep 22, 2025 |
Financial Forecast
Revenue This Year
93.15M
from 65.12M
Increased by 43.04%
Revenue Next Year
126.32M
from 93.15M
Increased by 35.60%
EPS This Year
-2.16
from -8.60
EPS Next Year
-1.90
from -2.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 97.5M | 139.4M | |
| Avg | 93.2M | 126.3M | |
| Low | 87.0M | 110.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 49.7% | 49.7% | |
| Avg | 43.0% | 35.6% | |
| Low | 33.6% | 19.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.11 | -1.40 | |
| Avg | -2.16 | -1.90 | |
| Low | -2.28 | -2.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.